Does NATALIZUMAB Cause Intestinal obstruction? 90 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Intestinal obstruction have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.1% of all adverse event reports for NATALIZUMAB.
90
Reports of Intestinal obstruction with NATALIZUMAB
0.1%
of all NATALIZUMAB reports
5
Deaths
74
Hospitalizations
How Dangerous Is Intestinal obstruction From NATALIZUMAB?
Of the 90 reports, 5 (5.6%) resulted in death, 74 (82.2%) required hospitalization, and 2 (2.2%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
Yes, Intestinal obstruction is listed as a known adverse reaction in the official FDA drug label for NATALIZUMAB.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
VEDOLIZUMAB (1,263)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
RISANKIZUMAB-RZAA (853)
BEVACIZUMAB (686)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
Which NATALIZUMAB Alternatives Have Lower Intestinal obstruction Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK